“…In terms of the pathophysiology of neuropsychiatric disorders, previous studies have identified human microglial cell activation based on conventional microglia-specific markers, including major histocompatibility complex, class II, DR (HLA-DR), complement receptor type3 (CD11b, also known as integrin, alpha-M; ITGAM), ionized calcium binding adaptor molecule 1 (IBA1, also known as allograft inflammatory factor 1; AIF1), macrophage antigen CD68, (CD68, also known as macrosialin), and glucose transporter type 5 (GLUT5, also known as solute carrier family 2, member 5; SLC2A5) [20,[24][25][26], in psychiatric illnesses, which are described below. Based on these observations, theories on the neuropsychoimmunological mechanisms of neuropsychiatric disorders have been proposed, including immunological alterations that have been demonstrated in peripheral blood and cerebrospinal fluid samples from patients with psychiatric illnesses.…”